Efficacy and Toxicity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

被引：0
|
作者：
De Divitiis, C. [1 ]
Ottaiano, A. [1 ]
Capozzi, M. [1 ]
Von Arx, C. [2 ]
Faggiano, A. [3 ]
Di Sarno, A. [4 ]
Tatangelo, F. [1 ]
Modica, R. [3 ]
Bianco, A. [4 ]
De Cicco, F. [3 ]
Colao, A. [3 ]
Tafuto, S. [1 ]
机构：
[1] Ist Nazl Tumori Fond G Pascale, Naples, Italy
[2] Imperial Coll, London, England
[3] Univ Naples Federico II, Naples, Italy
[4] AO Colli Monaldi Unit, Naples, Italy
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
neuroendocrine tumors; chemotherapy; temozolomide; metronomic treatment; second-line;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H08
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [21] Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma
    Yuji Takeyama
    Minoru Kato
    Chikako Nishihara
    Takeshi Yamasaki
    Taro Iguchi
    Satoshi Tamada
    Katsuyuki Kuratsukuri
    Tatsuya Nakatani
    International Journal of Clinical Oncology, 2018, 23 : 944 - 950
  • [22] Efficacy and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms
    Chatzellis, E.
    Angelousi, A.
    Daskalakis, K.
    Tsoli, M.
    Alexandraki, K.
    Wachula, E.
    Gross, D. J.
    Meirovitz, A.
    Grozinsky-Glasberg, S.
    Kos-Kudla, B.
    Koumarianou, A.
    Kaltsas, G.
    NEUROENDOCRINOLOGY, 2019, 108 : 146 - 146
  • [23] Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects
    Koumarianou, Anna
    Kaltsas, Gregory
    Kulke, Matthew H.
    Oberg, Kjell
    Strosberg, Jonathan R.
    Spada, Francesca
    Galdy, Salvatore
    Barberis, Massimo
    Fumagalli, Caterina
    Berruti, Alfredo
    Fazio, Nicola
    NEUROENDOCRINOLOGY, 2015, 101 (04) : 274 - 288
  • [24] Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
    Trevisani, Franco
    Brandi, Giovanni
    Garuti, Francesca
    Barbera, Maria Aurelia
    Tortora, Raffaella
    Gardini, Andrea Casadei
    Granito, Alessandro
    Tovoli, Francesco
    De Lorenzo, Stefania
    Inghilesi, Andrea Lorenzo
    Foschi, Francesco Giuseppe
    Bernardi, Mauro
    Marra, Fabio
    Sacco, Rodolfo
    Di Costanzo, Giovan Giuseppe
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (02) : 403 - 414
  • [25] Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure
    Granito, Alessandro
    Marinelli, Sara
    Terzi, Eleonora
    Piscaglia, Fabio
    Renzulli, Matteo
    Venerandi, Laura
    Benevento, Francesca
    Bolondi, Luigi
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (06) : 518 - 522
  • [26] Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
    Franco Trevisani
    Giovanni Brandi
    Francesca Garuti
    Maria Aurelia Barbera
    Raffaella Tortora
    Andrea Casadei Gardini
    Alessandro Granito
    Francesco Tovoli
    Stefania De Lorenzo
    Andrea Lorenzo Inghilesi
    Francesco Giuseppe Foschi
    Mauro Bernardi
    Fabio Marra
    Rodolfo Sacco
    Giovan Giuseppe Di Costanzo
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 403 - 414
  • [27] Temozolomide as Second-line Chemotherapy for Relapsed Gliomas
    S. Trent
    A. Kong
    S.C. Short
    D. Traish
    S. Ashley
    A. Dowe
    F. Hines
    M. Brada
    Journal of Neuro-Oncology, 2002, 57 : 247 - 251
  • [28] Temozolomide as second-line chemotherapy for relapsed gliomas
    Trent, S
    Kong, A
    Short, SC
    Traish, D
    Ashley, S
    Dowe, A
    Hines, F
    Brada, M
    JOURNAL OF NEURO-ONCOLOGY, 2002, 57 (03) : 247 - 251
  • [29] EFFICACY ANALYSIS OF APATINIB COMBINED WITH CHEMOTHERAPY IN THE TREATMENT OF ADVANCED SECOND-LINE GASTRIC CANCER
    Fan, Cuizhen
    Guo, Hongqiang
    Chu, Yuping
    An, Guangyu
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 1 - 5
  • [30] Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
    Shao, Y. -Y.
    Chen, B. -B.
    Ou, D. -L.
    Lin, Z. -Z.
    Hsu, C. -H.
    Wang, M. -J.
    Cheng, A. -L.
    Hsu, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (08) : 722 - 730
12345